Our innovative solution seamlessly integrates context knowledge with image information, catering to both structured reporting in clinical routine and the specific requirements of clinical trials. The easy-to-use radiology software provides assisted data capture, rendering all image information - incl. radiomics or tumor growth rate - readily accessible
Key benefits at a glance
Use Scenarios
mint Lesion™ is a radiology platform designed for a variety of applications, including routine clinical practice, clinical trials, and quantitative biomarker imaging research. It can be effortlessly configured to meet specific requirements in any context
In Clinical Routine All data in one place, ready for interdisciplinary collaboration
In Clinical Trials Verified read-ready platform to achieve high quality data with integrity
For Pharma and CRO Compliant, road-tested solution for comprehensive, reproducible data in real-time
In Imaging Biomarker Research Rapid evaluation and validation of imaging biomarkers based on high-quality, AI-compatible data
Our live demos are just as flexible as mint Lesion™ itself. We will customize your demo to your interests and a time that suits you.
loading...
What our users say about mint Lesion™
mint Lesion™ allows to efficiently conduct precise oncological treatment monitoring and communicate comprehensible reports to the clinical colleagues with a simple key stroke.
mint Lesion™ is an asset for the professionality and motivation of radiological tasks. Since the introduction of this software we have structured our evaluation procedure for clinical trials and are experiencing an effective improvement in the daily routine of oncological therapy evaluation.
mint Lesion™ is an innovative tool which helps radiologists in becoming central in oncologic multidisciplinary teams.
mint Lesion™ is an outstanding software that facilitates cancer proforma reporting and streamlines tumor treatment response assessment. Its functionality and versatility help radiologists do a better job!
Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.
mint Lesion™ allows for fast and adequate TNM staging and provides an excellent schematic overview of an individual patient’s disease for oncologists, surgeons, and the patients.
mint Lesion™ knows about the partially complex subtleties of assessment criteria, which makes the assessment of lesions a lot easier compared to conventional workstations.
Good integration in the existing IT was important to us – appropriate interfaces to RIS and PACS were implemented quickly and professionally.
By using mint Lesion™, we are able to generate standardized, complete and consistent oncologic reports. Not only can we describe all the important aspects of a particular tumor, but we are also storing important data in the background, which can be used for quality control and science.
The mint Lesion™ COVID-19 template is a tool that helps me and my colleagues to collect all important information about the patients – both clinical and imaging data. It is detailed and ensures a comprehensive standardized report.
mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.
The Mint Medical team has worked tirelessly with Imperial College London to develop and support an entire bespoke software platform to host the NIHR funded MROC study, from patient registration to the end of study. Co-ordinating CT and multiparametric MRI images, blinded double reads, treatment plans, surgical and histopathology findings and outcomes on the MROC platform has transformed the way we can deliver image-based clinical trials and bio-banking of study data.
Events
RSNA 2024
12/01
to
12/04/2024
Chicago, IL
Annual Meeting of the Radiological Society of North America
Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer
In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…
Developing Standardized Reporting Templates for Sarcomas: Insights from Prof. Dr. Wolfgang Kunz
Sarcomas are a rare and heterogeneous group of malignant tumors that pose significant challenges in both diagnosis and treatment. Within the framework…
RACOON FADEN Project Tackles Early Detection of Adenomyosis
Endometriosis is a vastly under-researched condition affecting women, but it is finally receiving the attention it deserves through the RACOON FADEN…
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.